| Margins | Company-estimated gross margins: ~62% IVD, ~45% MedTech, ~12% Solar EPC. |
|---|---|
| Order book | ~₹2,000 Cr secured; 100 MW+ solar in hand for two years. |
| Demand visibility | ₹3,000+ Cr pipeline; ~₹2,000 Cr secured renewables orders. |
| Management confidence | Promotional tone; 'exponential growth' claims unquantified. |
Growth
No H1 FY27 revenue or profit growth disclosed. Only market CAGRs cited, e.g. diagnostics 11.6%, genome testing 26.8%.
Outlook
Targets 2,000+ pathology labs, 1,000 Renal Care Units by March 2028; FY27 FPO, FY28 demerger planned. No growth guidance.
Risks
Import dependence, regulatory approvals and execution risk on government-linked pipeline. No risks quantified.
Investor Presentation filed with BSE, NSE: KRATOSENER. Summary written with AI assistance from the document.
Lords Mark Industries Ltd: key numbers
- Share price
- ₹68.55
- Market cap
- ₹2,924 Cr
- Revenue (annual)
- ₹684.8 Cr
- Net profit (annual)
- ₹48.59 Cr
- P/E (TTM)
- 28.4×Sector 21.2×
- Promoter holding
- 75.30%-4.54% QoQ
- FII holding
- 1.30%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Lords Mark Industries Ltd
All →Lords Mark Industries Earnings Call Transcript: Key Takeaways
Management cites Q2 FY27 consolidated revenue of ~₹411 Cr, EBITDA margin 18.82%, PAT margin 11.88%. Earlier published results were materially different and restated, which management admitted was an error.
Lords Mark Industries Results Correction
Lords Mark clarifies its September 2026 results error occurred under NCLT Monitoring Committee oversight. The Committee ceased 15 November 2026, returning control to company management.
Lords Mark Industries Q2 FY27 Results: Turns Profitable, Net Profit ₹48.8 Cr
Lords Mark Industries Ltd reported revenue from operations of ₹411.1 Cr (+3162.7% YoY) and net profit of ₹48.8 Cr for Q2 FY27.
- Key figure
- Net profit ₹48.8 Cr
Lords Mark Industries Q2 FY27 Results: Turns Profitable, Net Profit ₹17.3 Cr
Lord's Mark Industries' board approved unaudited September 2026 quarter and half-year results. Standalone net profit swung to Rs.47.99 Crore for H1 from a loss a year earlier.
- Key figure
- Net profit ₹17.3 Cr
Lords Mark Industries Board Meeting Date
Lord's Mark Industries Limited has intimated a board meeting on 14 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window stays closed from 1 October 2026 until 48 hours after results.
Lords Mark Industries Business Update
Lord's Mark showcased defence products from its investee Brahamastra, including BRAK RT and TRC-1. The promotional release discloses no orders, revenue, or quantified investment amount.